SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-211644
Filing Date
2014-05-23
Accepted
2014-05-23 17:15:07
Documents
4
Period of Report
2014-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d733498d8k.htm 8-K 16014
2 EX-10.1 d733498dex101.htm EX-10.1 103388
3 GRAPHIC g733498bmpic001.jpg GRAPHIC 110617
4 GRAPHIC g733498imag2.jpg GRAPHIC 51763
  Complete submission text file 0001193125-14-211644.txt   344679
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 14867910
SIC: 2834 Pharmaceutical Preparations